Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

+331G/A variant in the progesterone receptor gene, postmenopausal hormone use and risk of breast cancer.

International journal of cancer - 1 Oct 2009

Kotsopoulos Joanne, Tworoger Shelley S, De Vivo Immaculata, DeVivo Immaculata, Hankinson Susan E, Hunter David J, Willett Walter C, Chen Wendy Y

Abstract excerpt

A functional promoter polymorphism in the progesterone receptor (PR) gene previously has been associated with an increased risk of postmenopausal breast cancer. Whether the relationship between genetic variation in PR and risk of breast cancer is modified by postmenopausal hormone (PMH) use is unknown. Thus, we conducted a case-control study nested within the prospective Nurses' Health Study to evaluate if the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alanine
Share to Confidence Intervals

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Estrogen Replacement Therapy

Share to Glycine

Share to Postmenopause

Share to Receptors, Progesterone

Share to Risk Assessment

Share to United States

Source

Open in PubMed Open full text

Identifiers

PMID: 19462450
DOI: 10.1002/ijc.24477
PMCID: PMC2736114

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

+331G/A variant in the progesterone receptor gene, postmenopausal hormone use and risk of breast cancer.PMID 19462450Read ↗

A functional polymorphism in the promoter of the progesterone receptor gene associated with endometrial cancer risk.Semantic proximity Read ↗

A functional polymorphism in the progesterone receptor gene is associated with an increase in breast cancer risk.Semantic proximity Read ↗

No association between the progesterone receptor gene polymorphism (+331G/a) and the risk of breast cancer: an updated meta-analysis.Semantic proximity Read ↗

Association of a progesterone receptor gene +331 G/A polymorphism with breast cancer risk: a meta-analysis.Semantic proximity Read ↗

Genetic variation in the progesterone receptor gene and ovarian cancer risk.Semantic proximity Read ↗

Genetic variation in the progesterone receptor and metabolism pathways and hormone therapy in relation to breast cancer risk.Semantic proximity Read ↗

No association between a progesterone receptor gene promoter polymorphism (+331G>A) and breast cancer risk in Caucasian women: evidence from a literature-based meta-analysis.Semantic proximity Read ↗

Association of +331G/A PgR polymorphism with susceptibility to female reproductive cancer: evidence from a meta-analysis.Semantic proximity Read ↗

GATA5 activation of the progesterone receptor gene promoter in breast cancer cells is influenced by the +331G/A polymorphism.Semantic proximity Read ↗

No association between the progesterone receptor gene +331G/A polymorphism and breast cancer.Semantic proximity Read ↗

Progesterone Receptor Gene Polymorphisms and Breast Cancer Risk.Semantic proximity Read ↗

Polymorphism Thr160Thr in SRD5A1, involved in the progesterone metabolism, modifies postmenopausal breast cancer risk associated with menopausal hormone therapy.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.